Literature DB >> 16737916

Isochromosome 1q in a myelodysplastic syndrome after treatment for acute promyelocytic leukemia.

Attaphol Pawarode1, Esme Finlay, Sheila N J Sait, Maurice Barcos, Maria R Baer.   

Abstract

A growing body of literature reports therapy-related myelodysplastic syndrome (t-MDS) and acute myeloid leukemia (t-AML) in patients treated successfully for acute promyelocytic leukemia (APL). We report a t-MDS with an isochromosome 1q as a sole abnormality, 47,XY,+1,i(1)(q10), in a 46-year-old man with APL 14 years after he was treated with cytosine arabinosine and daunorubicin. The literature on t-MDS/t-AML after APL therapy and on isochromosome 1q is reviewed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16737916     DOI: 10.1016/j.cancergencyto.2005.11.013

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  3 in total

Review 1.  Rare cytogenetic abnormalities in myelodysplastic syndromes.

Authors:  Ulrike Bacher; Julie Schanz; Friederike Braulke; Detlef Haase
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-05-01       Impact factor: 2.576

2.  [Therapy-related myeloid neoplasms after successful treatment for acute promyelocytic leukemia: a report of four cases and literature review].

Authors:  Z Wang; M Z Xu; Y F Chen; F Xue; L Zhang; Y M Hu; C W Li; S Z Li; J X Wang; Y C Mi
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-12-14

3.  Secondary clonal hematologic neoplasia following successful therapy for acute promyelocytic leukemia (APL): A report of two cases and review of the literature.

Authors:  Daria Gaut; Joshua Sasine; Gary Schiller
Journal:  Leuk Res Rep       Date:  2018-04-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.